Survival Effect Difference of Whole-Brain Radiation Therapy and TKIs in Patients with Brain Metastases from Non-Small Cell Lung Cancer Stratified by EGFR Mutation Status

被引:0
|
作者
Li, Z. [1 ]
Zhang, J. [1 ]
Shen, D. [1 ]
Zhang, J. [1 ]
Han, H. [1 ]
Kong, D. [1 ]
Kong, J. [1 ]
Zhang, A. [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
关键词
D O I
10.1016/j.ijrobp.2018.07.941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO_25_269
引用
收藏
页码:E298 / E298
页数:1
相关论文
共 50 条
  • [1] EGFR mutation status on brain metastases from non-small cell lung cancer
    Hsu, Fred
    De Caluwe, Alex
    Anderson, David
    Nichol, Alan
    Toriumi, Ted
    Ho, Cheryl
    LUNG CANCER, 2016, 96 : 101 - 107
  • [2] The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status
    Shao, Jun
    Li, Jingwei
    Song, Lujia
    He, Qiuyao
    Wu, Yuxuan
    Li, Linhui
    Liu, Dan
    Wang, Chengdi
    Li, Weimin
    CANCER REPORTS, 2022, 5 (09)
  • [3] Efficacy of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer
    Koizumi, Tomonobu
    Sasaki, Shigeru
    Sakamoto, Akiyuki
    Kobayashi, Takashi
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 111 - 113
  • [4] Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer
    Welsh, J. W.
    Kim, E.
    Amini, A.
    Allen, P.
    Chang, J.
    Komaki, R.
    Nguyen, N.
    Holt, J.
    Erdman, D.
    Stea, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S136 - S136
  • [5] PHASE II STUDY OF ERLOTINIB WITH CONCURRENT WHOLE-BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
    Welsh, James
    Amini, Arya
    Kim, Edward
    Allen, Pamela K.
    Chang, Joe Y.
    Garland, Linda
    Komaki, Ritsuko
    Stea, Baldassarre
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1587 - S1587
  • [6] A phase I study of cediranib plus whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer
    Eichler, A. F.
    Shih, H. A.
    Sequist, L. V.
    Wen, P. Y.
    Jain, R. K.
    Sorensen, A. G.
    Batchelor, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases
    Luo, Dongdong
    Ye, Xin
    Hu, Zheng
    Peng, Kaiwen
    Song, Ye
    Yin, Xiaolu
    Zhu, Guanshan
    Ji, Qunsheng
    Peng, Yuping
    TUMOR BIOLOGY, 2014, 35 (03) : 2437 - 2444
  • [8] EGFR mutation status in brain metastases of non-small cell lung carcinoma
    Fanny Burel-Vandenbos
    Damien Ambrosetti
    Michael Coutts
    Florence Pedeutour
    Journal of Neuro-Oncology, 2013, 111 : 1 - 10
  • [9] EGFR mutation status in brain metastases of non-small cell lung carcinoma
    Burel-Vandenbos, Fanny
    Ambrosetti, Damien
    Coutts, Michael
    Pedeutour, Florence
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 1 - 10
  • [10] Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer
    Chen, Lingjuan
    Tong, Fang
    Peng, Ling
    Huang, Yu
    Yin, Ping
    Feng, Yue
    Cheng, Shishi
    Wang, Jing
    Dong, Xiaorong
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 44 - 51